Shanghai, China

Weiwei Mao

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jiangsu, CN (2020)
  • Shanghai, CN (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Weiwei Mao - Innovator in Pharmaceutical Compounds

Introduction

Weiwei Mao is a prominent inventor based in Shanghai, China, recognized for his contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. He holds an impressive portfolio of six patents, showcasing his innovative spirit and dedication to advancing medical research.

Latest Patents

Among Weiwei Mao's latest inventions, his patents include significant advancements in the area of JAK inhibitors. One notable patent describes a [1,2,4]triazolo[1,5-a]pyridine compound, highlighting its potential use in preparing a drug for treating diseases related to JAK1 and/or TYK2. This compound, represented by formula (I), includes isomers and pharmaceutically acceptable salts, reflecting the depth of his research and its applicability in medical treatments. Another patent further explores a class of compounds as JAK inhibitors for the preparation of medicaments for conditions associated with JAK and TYK2, again represented by formula (I), signifying the versatility of his contributions.

Career Highlights

Weiwei Mao has made his mark in the pharmaceutical industry through his roles at several significant companies. Notably, he has worked with Wuxi Fortune Pharmaceutical Co., Ltd and Zhuhai United Laboratories Co., Ltd., where he has been instrumental in advancing drug development projects. His expertise and innovative mindset have played a crucial role in the development of pharmaceutical compounds that aim to improve patient outcomes.

Collaborations

Throughout his career, Weiwei Mao has collaborated with notable colleagues, including Hao Wu and Shuhui Chen. These partnerships have fostered a collaborative environment that enhances research depth and innovation, leading to successful outcomes in their projects.

Conclusion

Weiwei Mao exemplifies the spirit of innovation in the pharmaceutical field. His contributions through patents focused on JAK inhibitors demonstrate his commitment to addressing medical challenges through effective and novel solutions. With his ongoing work and collaborations, Mao continues to be a significant figure in advancing therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…